---
title: "Quoin Pharmaceuticals (QNRX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/QNRX.US/norm.md"
symbol: "QNRX.US"
name: "Quoin Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/QNRX.US.md"
datetime: "2026-03-13T13:41:10.872Z"
locales:
  - [en](https://longbridge.com/en/quote/QNRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/QNRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/QNRX.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/QNRX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/QNRX.US/norm.md)


# Quoin Pharmaceuticals (QNRX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -6.72 | -6.30 | -6.50 | -12.41 | -16.45 |
| ROE | -2362.87% | -348.79% | -201.56% | -126.24% | -145.50% |
| Revenue | - | - | - | - | - |
| Net income | -3.95M | -3.70M | -3.81M | -2.31M | -2.35M |
| Operating income | -4.02M | -3.79M | -3.96M | -2.41M | -2.53M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.42M | 8.91M | 12.96M | 15.71M | 11.39M |
| Leverage | -5.29 | 3.49 | 2.19 | 1.71 | 2.09 |
| BVPS | -2.07 | 4.34 | 10.07 | 36.00 | 37.72 |
| Turnover | - | - | - | - | - |
| Cash & STI | 5.41M | 7.79M | 11.55M | 14.06M | 10.31M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -2.94M | -5.17M | -8.78M | -11.13M | -7.23M |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.23M | -3.69M | -2.59M | -2.24M | -2.18M |
| Investing CF | 2.54M | 1.68M | 2.77M | -3.18M | 2.60M |
| Financing CF | -150000.00 | -150000.00 | 22958.00 | 5.92M | -149892.00 |
| Free CF | -792120.00 | -2.29M | -1.49M | -1.12M | -1.26M |
| OCF coverage | -1483.64% | -2457.55% | -1729.45% | -1491.01% | -1452.86% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |